Akèy › Tit travay › Analytical Chemist
Analytical Chemist: Salè H-1B
139 aplikasyon kondisyon travay te itilize tit travay Analytical Chemist. Salè baz medyàn ofri $79,957; mwatye mitan $65,000–$85,597.
Demann (LCA)139
Salè medyan ofri$79,957
Mwatye salè yo$65,000–$85,597
10yèm–90yèm pousantaj$62,500–$99,700
Avoka imigrasyon, rekritè oswa anplwayè? Mete sèvis ou an tèt paj sa a — $99 pou 30 jou →
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|
| Ascent Pharmaceuticals, Inc. | 14 | $73,800 |
| Sciegen Pharmaceuticals Inc. | 10 | $83,250 |
| KVK-Tech, Inc. | 7 | $83,000 |
| Aptapharma, Inc | 6 | $74,526 |
| Accuon Labs Inc. | 6 | $73,950 |
| Innogenix Inc | 5 | $73,500 |
| Purdue University | 4 | $72,405 |
| Frontline Biotechnologies Inc. | 4 | — |
| Brio Pharmaceuticals Inc | 4 | $80,891 |
| Novitium Pharma LLC. | 4 | $62,500 |
| Eurofins SF Analytical Laboratories, Inc. | 3 | $52,312 |
| The Veritas Healthcare Solutions LLC | 3 | $69,254 |
| PureBioX, Inc. | 3 | — |
| Pharmaceutics International, Inc. | 2 | $92,500 |
| Splint Pharma LLC | 2 | $70,636 |
| Dipna RX Inc. | 2 | $81,000 |
| Battelle Memorial Institute | 2 | $140,145 |
| United Pharma Technologies, Inc. | 2 | $83,803 |
| RK Pharma Inc | 2 | $132,500 |
| InvaTech Pharma Solutions LLC | 2 | $72,500 |
| Vitacare Pharma LLC | 2 | $81,194 |
| Knack Ny Inc | 2 | $78,374 |
| Corteva Agriscience LLC | 2 | $98,390 |
| Nucleus RadioPharma, Inc. | 2 | $112,500 |
| Biolink Life Sciences Carolinas Inc. | 2 | $63,000 |
| Gowan Company, LLC | 2 | $82,560 |
| Biocon Generics Inc. | 2 | $84,000 |
| VAStek Inc. | 1 | — |
| Stira Pharmaceuticals LLC | 1 | $80,000 |
| Master Compliance, Inc. | 1 | $71,000 |
| Sannova Analytical LLC | 1 | $85,000 |
| Battelle Energy Alliance, LLC | 1 | $106,884 |
| Evonik Corporation | 1 | $54,413 |
| Penn Life Sciences, LLC | 1 | $85,000 |
| Carlisle Construction Materials LLC | 1 | $70,000 |
| TechLaw Consultants, Inc. | 1 | $94,557 |
| VPS Testing & Inspection, Inc. | 1 | $85,888 |
| Eurofins Xenco LLC | 1 | $46,000 |
| Pain Management Centers of America PSC | 1 | $65,000 |
| Shree Meldi Krupa LLC | 1 | $119,500 |
| Continuus Pharmaceuticals Inc. | 1 | $115,000 |
| Everest Life Sciences LLC | 1 | $96,000 |
| Odin Pharmaceuticals, LLC | 1 | $88,000 |
| Rna Corporation | 1 | $77,688 |
| Bactolac Pharmaceutical Inc. | 1 | $65,000 |
| Evaric Pharmaceuticals Inc. | 1 | $62,000 |
| Health Pharma USA LLC | 1 | $61,000 |
| Jacam Catalyst, LLC | 1 | $85,000 |
| Clarkson University | 1 | $68,000 |
| Versum Materials US, LLC | 1 | $92,000 |
| Nextcea, Inc. | 1 | $120,000 |
| Inentec, Inc. | 1 | $75,130 |
| APPCO Pharma LLC | 1 | $65,000 |
| LanceSoft Inc. | 1 | $100,000 |
| RevoChem LLC | 1 | — |
| TEKsystems Global Services, LLC | 1 | $119,600 |
| Bunge North America, Inc. | 1 | $77,277 |
| Rasi Laboratories, Inc. | 1 | $63,086 |
| Shirley Diagnostics, Inc. | 1 | $72,426 |
| EMD Performance Materials Corporation | 1 | — |
Pa nivo salè
| Nivo revni | Salè medyan |
|---|
| Nivo I (antre) | $65,001 |
| Nivo II (kalifye) | $82,000 |
| Nivo III (eksperyans) | $106,884 |
| Nivo IV (plen kompetans) | $97,781 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|
| FY2023 | 32 | $80,000 |
| FY2024 | 29 | $80,000 |
| FY2025 | 39 | $74,000 |
| FY2026 | 24 | $80,457 |
Vil yo
- Hauppauge, NY18
- Central Islip, NY14
- Newtown, PA7
- Saint Paul, MN7
- Pennsauken, NJ6
- Amityville, NY5
- Houston, TX5
- East Windsor, NJ5
- West Lafayette, IN4
- Indianapolis, IN4
- Pearl River, NY4
- South Plainfield, NJ4
- Charles City, IA3
- Cranbury, NJ3
- Hunt Valley, MD2
- Bronx, NY2
- Richland, WA2
- Somerset, NJ2
- East Brunswick, NJ2
- Woburn, MA2
- Rochester, MN2
- Cary, NC2
- Yuma, AZ2
- Fairfield, NJ1
- Salisbury, MD1
- Idaho Falls, ID1
- Little Rock, AR1
- Langhorne, PA1
- Carlisle, PA1
- Edison, NJ1
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).